Acuis.ai
Acuis Daily is written by AI based on official sources. It may contain errors or omissions. Acuis Daily is for information purposes only. It is not legal or professional advice. Always check the official source before relying on an entry.
6 Nov 2026
/
EFSA
/
Report

EFSA finds no safety concerns with wider use of phospholipase A1 food enzyme

EFSA assessed Novozymes A/S’s request to extend use of phospholipase A1, produced with genetically modified Aspergillus oryzae strain NZYM-LJ, to three additional food manufacturing processes. It concluded that the enzyme raises no safety concerns under the revised intended conditions of use, covering four processes in total.

Importance
Noteworthy
Why it matters
The scientific assessment supports evaluation of an enzyme’s expanded use in food manufacturing but does not itself authorise those uses.
Institution
EFSA
Audience
Regulatory affairs teamsHealth and safety teams
Tags
Health
Sectors
Food, drink, and tobacco